See more : Lipocine Inc. (LPCN) Income Statement Analysis – Financial Results
Complete financial analysis of Bharat Parenterals Limited (BPLPHARMA.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bharat Parenterals Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- EQ Health Acquisition Corp. Red (EQHA-WT) Income Statement Analysis – Financial Results
- Sinopec Shanghai Petrochemical Company Limited (SHI) Income Statement Analysis – Financial Results
- Chase Mining Corporation Limited (CML.AX) Income Statement Analysis – Financial Results
- Innovacom Inc. (MPEG) Income Statement Analysis – Financial Results
- CK Hutchison Holdings Limited (CKHUF) Income Statement Analysis – Financial Results
Bharat Parenterals Limited (BPLPHARMA.BO)
About Bharat Parenterals Limited
Bharat Parenterals Ltd. engages in the manufacture of pharmaceutical formulations. Its products include general medicines, B-Lactam, cephalosporins, anti-retroviral and veterinary medicines. The company was founded by Ramesh Desai on September 3, 1992 and is headquartered in Vadodara, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.59B | 2.18B | 2.12B | 2.05B | 2.28B | 2.20B | 1.37B | 1.11B | 1.20B | 1.19B | 1.14B |
| Cost of Revenue | 1.60B | 1.75B | 1.68B | 1.64B | 1.81B | 1.72B | 1.13B | 1.02B | 834.08M | 870.26M | 822.54M |
| Gross Profit | 989.47M | 430.21M | 435.85M | 403.24M | 475.86M | 477.33M | 231.90M | 93.76M | 363.28M | 317.17M | 314.17M |
| Gross Profit Ratio | 38.14% | 19.74% | 20.56% | 19.70% | 20.86% | 21.74% | 16.98% | 8.41% | 30.34% | 26.71% | 27.64% |
| Research & Development | 10.33M | 10.49M | 14.19M | 17.10M | 21.62M | 22.73M | 12.93M | 7.09M | 0.00 | 8.78M | 3.04M |
| General & Administrative | 227.82M | 418.82M | 187.22M | 179.34M | 217.49M | 216.81M | 148.19M | 74.24M | 99.31M | 77.99M | 75.52M |
| Selling & Marketing | 17.55M | 7.67M | 6.23M | 5.51M | 8.28M | 5.13M | 2.15M | 3.04M | 1.62M | 2.30M | 3.05M |
| SG&A | 245.37M | 266.10M | 193.45M | 184.85M | 225.77M | 221.95M | 150.34M | 77.28M | 100.93M | 80.29M | 78.57M |
| Other Expenses | 0.00 | -176.00K | -453.00K | -1.06M | -1.36M | -657.00K | -626.00K | -205.00K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 255.98M | 276.77M | 208.09M | 203.01M | 248.75M | 245.33M | 163.90M | 84.57M | 264.84M | 216.33M | 259.12M |
| Cost & Expenses | 1.86B | 2.03B | 1.89B | 1.85B | 2.05B | 1.96B | 1.30B | 1.11B | 1.10B | 1.09B | 1.08B |
| Interest Income | 0.00 | 3.59M | 16.75M | 3.54M | 4.68M | 2.45M | 1.99M | 3.64M | 4.99M | 13.76M | 9.07M |
| Interest Expense | 32.20M | 21.90M | 13.06M | 7.65M | 8.65M | 8.70M | 9.40M | 9.06M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 89.30M | 57.84M | 65.51M | 59.09M | 58.82M | 60.70M | 55.72M | 57.91M | 42.04M | 42.16M | 30.32M |
| EBITDA | 265.74M | 319.27M | 293.28M | 337.99M | 330.18M | 390.04M | 133.40M | 101.03M | 150.18M | 146.65M | 73.31M |
| EBITDA Ratio | 10.24% | 9.69% | 13.83% | 12.67% | 12.53% | 13.33% | 9.06% | 6.02% | 12.54% | 12.35% | 6.45% |
| Operating Income | 733.49M | 153.45M | 227.76M | 200.23M | 227.12M | 232.00M | 68.00M | 9.20M | 108.15M | 104.48M | 42.99M |
| Operating Income Ratio | 28.28% | 7.04% | 10.74% | 9.78% | 9.95% | 10.57% | 4.98% | 0.83% | 9.03% | 8.80% | 3.78% |
| Total Other Income/Expenses | -546.27M | 82.02M | 51.00M | 71.02M | 100.84M | 113.92M | 59.91M | 65.60M | -168.90M | -141.01M | 3.00M |
| Income Before Tax | 187.22M | 235.47M | 278.77M | 271.25M | 327.96M | 345.93M | 127.92M | 74.79M | 93.46M | 87.09M | 45.98M |
| Income Before Tax Ratio | 7.22% | 10.80% | 13.15% | 13.25% | 14.37% | 15.76% | 9.37% | 6.71% | 7.81% | 7.33% | 4.05% |
| Income Tax Expense | 82.07M | 78.32M | 70.65M | 68.09M | 86.53M | 133.45M | 36.76M | 5.85M | 28.92M | 12.70M | 19.47M |
| Net Income | 145.17M | 164.40M | 210.53M | 203.89M | 241.43M | 212.47M | 91.16M | 68.94M | 64.53M | 74.38M | 65.46M |
| Net Income Ratio | 5.60% | 7.54% | 9.93% | 9.96% | 10.58% | 9.68% | 6.67% | 6.19% | 5.39% | 6.26% | 5.76% |
| EPS | 24.94 | 28.47 | 36.67 | 35.59 | 42.14 | 37.08 | 15.91 | 12.03 | 11.26 | 12.98 | 11.42 |
| EPS Diluted | 24.94 | 28.47 | 36.67 | 35.59 | 42.14 | 37.08 | 15.91 | 12.03 | 11.26 | 12.98 | 11.42 |
| Weighted Avg Shares Out | 5.82M | 5.77M | 5.74M | 5.73M | 5.73M | 5.73M | 5.73M | 5.73M | 5.73M | 5.73M | 5.73M |
| Weighted Avg Shares Out (Dil) | 5.82M | 5.77M | 5.74M | 5.73M | 5.73M | 5.73M | 5.73M | 5.73M | 5.73M | 5.73M | 5.73M |
Source: https://incomestatements.info
Category: Stock Reports